Skip to content

Clinical Trial of Disposable Colonoscope for Lower Gastrointestinal Examination and Treatment with EndoTherapy Accessories

Clinical Trial of Disposable Colonoscope for Lower Gastrointestinal Examination and Treatment with EndoTherapy Accessories

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040638
Enrollment
Unknown
Registered
2020-12-05
Start date
2021-01-04
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Disease

Interventions

Group 1:XZING-W200B Colonoscopy + Biopsy +EMR
2:GIF-HQ290+Biopsy+EMR

Sponsors

HuiZhou Xzing Technology Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. The age ranged from 18 to 75 years old; 2. Electronic colonoscopy and / or treatment are needed; 3. Voluntarily participate in the clinical trial and have signed a written informed consent form;

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications for colonoscopy: (1) patients with abdominal aneurysm; (2) patients with peritonitis or intestinal perforation; (3) patients with severe cardiovascular and cerebrovascular diseases; (4) Acute radiation colitis patients; (5) advanced tumor with pelvic metastasis and (or) obvious ascites; (6) severe and extensive adhesion after abdominal or pelvic surgery; (7) patients with systemic hemorrhagic disease, or coagulation dysfunction and bleeding tendency; (8) female patients during menstruation; (9) patients with mental illness or severe mental retardation who can not cooperate with endoscopy; (10) Colonosis Diverticulum; 2. Patients with previous history of colectomy; 3. Pregnant and lactating women; 4. Emergency colonoscopy and / or treatment; 5. Those who participated in other clinical trials one month before screening; 6. Patients who need other gastrointestinal endoscopy and / or treatment on the same day; 7. Those who have been allergic to narcotic drugs in the past; 8. The researcher thinks that it is not suitable to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Cecal intubation Rate;AE incidence rate;

Secondary

MeasureTime frame
Image Quality Scoring;Device failure rate;Operating Time;

Countries

China

Contacts

Public ContactPeng Li

Capital Medical University Affiliated Beijing Friendship Hospital

lipeng@ccmu.edu.cn+86 010-63139206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026